Zura Bio (ZURA) Change in Accured Expenses (2022 - 2026)

Zura Bio's Change in Accured Expenses history runs 5 years deep, the most recent figure standing at -$1.2 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 177.39% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was -$5.0 million, a 177.56% decrease from a year earlier, with the FY2025 full-year figure at -$2.2 million, down 151.33% from the prior year.
• Change in Accured Expenses rose to -$1.2 million in Q1 2026 per ZURA's latest filing, from -$3.1 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.4 million in Q3 2023 and bottomed at -$3.1 million in Q4 2025.
• The 5-year median for Change in Accured Expenses is $394000.0 (2024), against an average of $619000.0.
• Across the five-year window, Change in Accured Expenses jumped 1194.74% in 2023 and plunged 722.08% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $3.1 million in 2022, then advanced by 6.42% to $3.3 million in 2023, then slumped by 34.65% to $2.2 million in 2024, then sank by 242.36% to -$3.1 million in 2025, then jumped by 60.35% to -$1.2 million in 2026.
• Per Business Quant, the three latest ZURA Change in Accured Expenses figures stand at -$1.2 million (Q1 2026), -$3.1 million (Q4 2025), and $1.8 million (Q3 2025).